{"id":935586,"date":"2026-02-10T09:56:04","date_gmt":"2026-02-10T14:56:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\/"},"modified":"2026-02-10T09:56:04","modified_gmt":"2026-02-10T14:56:04","slug":"day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\/","title":{"rendered":"Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p>BRISBANE, Calif., Feb.  10, 2026  (GLOBE NEWSWIRE) &#8212; Day One Biopharmaceuticals (Nasdaq: DAWN) (\u201cDay One\u201d or the \u201cCompany\u201d), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced it will host a live conference call and webcast on Tuesday, February 24, 2026 at 4:30 p.m. ET to report financial results and discuss corporate progress for the fourth quarter and full-year 2025.<\/p>\n<p>Live audio of the webcast will be accessible by visiting the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dpPlObBCF7efWT68B63TbCGRW_tgycUJGnxdKeIe3bdbUCKgsxrl8X34GAf4VLqCEuvCvBrbqGEQOUKhM9TYbHDhivhgEOUOj2RY8Ii07F0=\" rel=\"nofollow\" target=\"_blank\">Events<\/a> section of Day One\u2019s Media &amp; Investors page. An archived version of the webcast will be available for replay in the Events section for 30 days following the event.<\/p>\n<p>\n        <strong>About Day One Biopharmaceuticals<\/strong>\n      <\/p>\n<p>Day One Biopharmaceuticals is a commercial-stage biopharmaceutical company that believes when it comes to pediatric cancer, we can do better. The Company was founded to address a critical unmet need: the dire lack of therapeutic development in pediatric cancer. Inspired by \u201cThe Day One Talk\u201d that physicians have with patients and their families about an initial cancer diagnosis and treatment plan, Day One aims to re-envision cancer drug development and redefine what\u2019s possible for all people living with cancer &#8211; regardless of age &#8211; starting from day one.<\/p>\n<p>Day One partners with leading clinical oncologists, families, and scientists to identify, acquire, and develop important targeted cancer treatments. The Company\u2019s pipeline includes tovorafenib (OJEMDA\u2122), DAY301, and following the recently announced acquisition of Mersana Therapeutics, Emi-Le (emiltatug ledadotin), a novel antibody drug conjugate (ADC) targeting the B7-H4 protein in clinical development to treat the rare cancer adenoid cystic carcinoma (ACC).<\/p>\n<p>Day One is based in Brisbane, California. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LC60fzybeJ7qbQ1zfhLyX8WF8nI3teBHmiTZ1_LykHn8e-0Aqn76Cxu07B5--GZX0V0kZD5gt-cVE9_7IJcy7LmCZwPtb9YIQzR-gxYXMEo=\" rel=\"nofollow\" target=\"_blank\">www.dayonebio.com<\/a> or find the Company on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=C2W3cAKY49RkVhTHLDbG48dXosffSDEVMw0qYBhg8xFdVHKp2bBExUE96siB2zLTfMYNPuurbgph8eSPaxx5NKyI2OtRjiYsncCrQqMb6ko=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a> or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uDQpIKqI2Nw3_LbMKcuNu7CCnHDksDEWk7GA91i-WIn3SiJgcE6Bp2pUqLNA1ewWqOL63oFOBscToxMXqlrCuA==\" rel=\"nofollow\" target=\"_blank\">X<\/a>.<\/p>\n<p>DAY ONE MEDIA<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JrEb4HOzAO1OoO2pOwSe5rY1UHVEXfARYlDCHR5mh2fFcje0DfXfOCPKirGtqTqCkeJKVc0bFW6wBaduZpDm_m5GtZu52qc1ML32q7s1JScRDeUsylRZxXLqdl1cIUHNYr9n03gt71pYeHXqKAma6p8lw5JA7rFORI3C6owUXfpPTGb7jFuOOmP3lFcUpq_c7-dlh1BfnC46Oqi4BPyrvFJiEd3jOUBLZuPk7CC_P7hfEroK2234V8vojcul-0uC8ihXpS53kHsWwC6iVdd4Og==\" rel=\"nofollow\" target=\"_blank\">media@dayonebio.com<\/a><\/p>\n<p>DAY ONE INVESTORS<br \/>LifeSci Advisors, PJ Kelleher<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=u-xDNsfSjxpqXZc7piaH8LmJh_P3IIeptrGNB5ruupzdPmxwqrab5MtMC18aMuSfx0ITBSSSD9pQEv4mFrhJpiZtGaa4aQkZIRLnHx0VZ0s8gP5RNXcbS4w7QKxmJCER7LqFWAIigK4HpAZO2H_wZAHuf0ecwJ0W7y9_0G4bUkx7IHS5T-nxX_0mvEMv-zshNSYdUou2pvfPxTcthxREoTyDA2Lezd2WLpjsKSjKvr6XC82EwiUao4H7tA1PdHHzxETH8UZdd-7CfRiSfe601H4LNPdRFM9b_w2w1101mkQzqgPXo-X9jvsRDBmTVQd_\" rel=\"nofollow\" target=\"_blank\">pkelleher@lifesciadvisors.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MTQ2NyM3NDE3MDI1IzIyMDkxNjE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MzYyZTE1NjktOTliZS00MzQ1LTlmZjItOWYwOTE1MGIwM2RiLTEyMjA3MTQtMjAyNi0wMi0xMC1lbg==\/tiny\/Day-One-Biopharmaceuticals-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BRISBANE, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) &#8212; Day One Biopharmaceuticals (Nasdaq: DAWN) (\u201cDay One\u201d or the \u201cCompany\u201d), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced it will host a live conference call and webcast on Tuesday, February 24, 2026 at 4:30 p.m. ET to report financial results and discuss corporate progress for the fourth quarter and full-year 2025. Live audio of the webcast will be accessible by visiting the Events section of Day One\u2019s Media &amp; Investors page. An archived version of the webcast will be available for replay in the Events section for 30 days following the event. About Day One Biopharmaceuticals Day One Biopharmaceuticals is &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-935586","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BRISBANE, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) &#8212; Day One Biopharmaceuticals (Nasdaq: DAWN) (\u201cDay One\u201d or the \u201cCompany\u201d), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced it will host a live conference call and webcast on Tuesday, February 24, 2026 at 4:30 p.m. ET to report financial results and discuss corporate progress for the fourth quarter and full-year 2025. Live audio of the webcast will be accessible by visiting the Events section of Day One\u2019s Media &amp; Investors page. An archived version of the webcast will be available for replay in the Events section for 30 days following the event. About Day One Biopharmaceuticals Day One Biopharmaceuticals is &hellip; Continue reading &quot;Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-10T14:56:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MTQ2NyM3NDE3MDI1IzIyMDkxNjE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026\",\"datePublished\":\"2026-02-10T14:56:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\\\/\"},\"wordCount\":312,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MTQ2NyM3NDE3MDI1IzIyMDkxNjE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\\\/\",\"name\":\"Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MTQ2NyM3NDE3MDI1IzIyMDkxNjE=\",\"datePublished\":\"2026-02-10T14:56:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MTQ2NyM3NDE3MDI1IzIyMDkxNjE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MTQ2NyM3NDE3MDI1IzIyMDkxNjE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\/","og_locale":"en_US","og_type":"article","og_title":"Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026 - Market Newsdesk","og_description":"BRISBANE, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) &#8212; Day One Biopharmaceuticals (Nasdaq: DAWN) (\u201cDay One\u201d or the \u201cCompany\u201d), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced it will host a live conference call and webcast on Tuesday, February 24, 2026 at 4:30 p.m. ET to report financial results and discuss corporate progress for the fourth quarter and full-year 2025. Live audio of the webcast will be accessible by visiting the Events section of Day One\u2019s Media &amp; Investors page. An archived version of the webcast will be available for replay in the Events section for 30 days following the event. About Day One Biopharmaceuticals Day One Biopharmaceuticals is &hellip; Continue reading \"Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-10T14:56:04+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MTQ2NyM3NDE3MDI1IzIyMDkxNjE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026","datePublished":"2026-02-10T14:56:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\/"},"wordCount":312,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MTQ2NyM3NDE3MDI1IzIyMDkxNjE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\/","name":"Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MTQ2NyM3NDE3MDI1IzIyMDkxNjE=","datePublished":"2026-02-10T14:56:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MTQ2NyM3NDE3MDI1IzIyMDkxNjE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MTQ2NyM3NDE3MDI1IzIyMDkxNjE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/day-one-to-report-fourth-quarter-and-full-year-2025-financial-results-tuesday-february-24-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/935586","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=935586"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/935586\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=935586"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=935586"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=935586"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}